Follow-up care for people five years after bariatric surgery who were lost to follow-up
Official title: Evaluation of the Care Provided to Patients Who Underwent Bariatric Surgery and Were Lost to Follow-up 5 Years After Surgery
Run by Central Hospital, Nancy, France · NCT07118540 · Data updated 2026-11-12
This project will try to compare health outcomes and care needs for people who had bariatric surgery and either were lost to follow-up or remained under follow-up five years after their operation.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 65 Years |
| Sex | All |
| Enrollment | 176 (estimated) |
| Sponsor | Central Hospital, Nancy, France Academic / other |
| Locations | 2 sites (Nancy, Lorraine and 1 other locations) |
| Status | Recruiting |
| Started | June 1, 2025 |
| Main results expected | October 10, 2025 |
| Study ends | October 10, 2025 |
| Registry record updated | August 12, 2025 |
| Trial ID | NCT07118540 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are patients included in the OBESEPI cohort who had bariatric surgery at Nancy University Hospital between 2013 and 2018, meet HAS surgical criteria (BMI > 40 or BMI > 35 with complications), and have not objected to use of their data.
✕Probably not a fit
Patients not in the OBESEPI cohort, those who object to participation or data use, pregnant or breastfeeding women, people under legal guardianship or curatorship, and those deprived of liberty are excluded and will not benefit from this project.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Using the OBESEPI cohort from Nancy University Hospital, researchers will identify patients who underwent bariatric surgery between 2013 and 2018 and compare those lost to follow-up at five years with those still being monitored. Participation involves a single 30-minute questionnaire and review of medical records; the inclusion period is 3 months and the total project duration is 9 months. Eligible patients met French HAS criteria for surgery (BMI > 40 or BMI > 35 with obesity-related complications). Patients are classified as lost to follow-up if there is no record of a visit to the surgical department five years after inclusion.
Why it matters
Potential benefit: If successful, the project could reveal where long-term care breaks down and guide steps to improve lifelong monitoring to prevent nutritional deficiencies and other complications after bariatric surgery.
How similar studies have gone: Previous cohort studies have consistently shown high rates of loss to follow-up after bariatric surgery and linked this to nutritional complications, but interventions to reliably prevent loss to follow-up have had limited and mixed success.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * \> Patients included in the OBESEPI cohort; * Individuals who have received complete information about the organisation of the research and have not objected to their participation and the use of their data; * Affiliation with a social security scheme. Exclusion Criteria: * \>Patient who objects to participating in this research; * Pregnant and breastfeeding women; * Patients under legal guardianship or curatorship; * Patients deprived of their liberty by a judicial or administrative decision.
Where it's running
-
Centre Hospitalier Universitaire de Nancy
Nancy, Lorraine, France Recruiting -
Centre Hospitalier Universitaire de Nancy
Nancy, Lorraine, France Enrolling by invitation
Study contacts
- Study coordinator: Claire NOMINE-CRIQUI, MD
- Email: c.nomine-criqui@chru-nancy.fr
- Phone: +33632149814
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Supervised exercise after bariatric surgery to protect muscle and bone
This program tests whether supervised exercise after gastric bypass or sleeve surgery helps preserve muscle mass and bone density in adults.
-
Comparing a standard versus an intensified interactive Get Ready app to support patients having bariatric surgery
This trial tests whether an intensified, interactive version of the Get Ready smartphone app helps people having bariatric surgery follow their pre- and post‑operative plan better than the standard app.
-
Phase 1/2a: RN3161 alone and with tirzepatide for safety, how the drug works in the body, and effects on weight in adults with overweight or obesity
This trial will test RN3161 by itself in healthy volunteers and RN3161 with tirzepatide in adults with overweight or obesity to see if it is safe and changes body weight.
-
Grape powder effects on gut and immune health in adults with obesity
This 12-week test will see if taking 48 g per day of freeze-dried grape powder changes the gut microbiome and immune markers in adults aged 30–45 with obesity.
-
Probiotic Support for GLP-1 RA Weight Loss in Obesity
This study tests whether adding probiotics helps people starting GLP-1 receptor agonist treatment for obesity see if they tolerate the medication better and possibly lose more weight.
-
Managing multiple medications in older adults with chronic diseases
This project will see if taking many different medicines changes the health outlook of people aged 65 and older who have chronic conditions.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.